The Journal of Emergency Medicine
Volume 24, Issue 1 , Page 91 , January 2003

Letter to the editor

References 

  1. Mehta RN, Mehta NJ, Gulati A. Late rebound digoxin toxicity after digoxin-specific antibody fragments therapy in anuric patient. J Emerg Med. 2002;22:203–206
  2. Howland MA. Digoxin-specific antibody fragments (Fab). In:  Goldrank LR,  Flomenbaum NE,  Lewin N,  Howland MA,  Hoffman R,  Nelson L editor. Goldfrank’s toxicologic emergencies. Stamford, CT: Appleton & Lange; 1998;p. 801–807 6thedn
  3. Antman EM, Wenger TL, Butler VP, et al.  Treatment of 150 cases of life threatening digitalis intoxication with digoxin-specific Fab antibody fragments (final report of a multicenter study). Circulation. 1990;81:1744–1752
  4. Ujhelyi MR, Robert S, Cummings DM, et al.  Influence of digoxin immune Fab therapy and renal dysfunction on the disposition of total and free digoxin. Ann Intern Med. 1993;119:273–277
  5. Ujhelyi MR, Robert S. Pharmacokinetic aspects of digoxin-specific Fab therapy in the management of digitalis toxicity. Clin Pharmacokinet. 1995;6:483–493
  6. Dart RL, Seifert SA, Carroll L, et al.  Affinity-purified, mixed monospecific crotalid antivenom ovine Fab for the treatment of crotalid venom poisoning. Ann Emerg Med. 1997;30:33–39

PII: S0736-4679(02)00683-2

doi: 10.1016/S0736-4679(02)00683-2

The Journal of Emergency Medicine
Volume 24, Issue 1 , Page 91 , January 2003

Article Tools